Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Revenue ContractionContracting
Percentile Rank93
3Y CAGR+15.4%
5Y CAGR+10.1%
Year-over-Year Change
Total revenue from sales of goods and services
3Y CAGR
+15.4%/yr
vs +0.5%/yr prior
5Y CAGR
+10.1%/yr
Recent acceleration
Acceleration
+14.9pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $593000.00 | -13.2% |
| 2024 | $683000.00 | +40.0% |
| 2023 | $488000.00 | +26.4% |
| 2022 | $386000.00 | +7.5% |
| 2021 | $359000.00 | -1.9% |
| 2020 | $366000.00 | +49.6% |
| 2019 | $244632.00 | -35.3% |
| 2018 | $378000.00 | -25.1% |
| 2017 | $505000.00 | +32.5% |
| 2016 | $381000.00 | - |